Figures
Abstract
Background
Enterovirus 71 (EV71) vaccine, which was put into market in China in 2016, has been viewed as a promising prevention measure against severe and fatal hand, foot and mouth disease (HFMD). This study aimed to investigate the knowledge of HFMD and acceptability of EV71 vaccine among parents of under-five in Chongqing, China.
Methodology /Principal findings
A cross-sectional survey was conducted in 2017. A validated questionnaire consisting of three sections including demographic information, knowledge of HFMD, acceptability and reasons for declining vaccination was developed based on literature review. Factors associated with unwillingness to receive EV71 vaccine were explored using multivariate logistic regression. A total of 992 parents finished the questionnaire with a response rate of 91.9%. Awareness of HFMD and EV71 vaccine were reported by 823 (83.0%) parents and 386 (38.9%) parents respectively. Knowledge about HFMD was with a mean score of 5.0 (standard deviation = 3.5) out of a total score of 12. Only 369 (37.2%) participants were classified as with good knowledge level about HFMD. 279 (28.1%) participants had their children received EV71 vaccine and 271 (27.3%) expressed willingness to vaccinate their children after a short-time education about EV71 vaccine. Acceptability of EV71 vaccine increased along with parents’ education level (p = 0.008) and HFMD knowledge level (p<0.001). Parents of scattered children had higher acceptability than those of preschool children (p = 0.002). 442 (44.6%) of participants were unwilling to have their children vaccinated with EV71 vaccine. The most common reasons for declining EV71 vaccine were doubts about its safety (56.6%) and efficacy (48.3%), and the necessity of vaccination (38.3%). Physicians and vaccination certificate were the parents’ most trusted sources of vaccine information.
Conclusions
Parents’ knowledge about HFMD was not sufficient, and nearly half of the parents expressed unwillingness to vaccinate their children with EV71 vaccine. Our findings stress that more efforts by health authorities in Chongqing are needed to increase the acceptability of EV71 vaccine, especially among parents of preschool children with lower education level.
Citation: Qi L, Su K, Xia Y, Tang W, Shen T, Li Q (2019) Enterovirus 71 vaccine acceptance among parents of children < 5 years old and their knowledge of hand, foot and mouth disease, Chongqing, China, 2017. PLoS ONE 14(11): e0225569. https://doi.org/10.1371/journal.pone.0225569
Editor: Eric HY Lau, The University of Hong Kong, CHINA
Received: January 22, 2019; Accepted: November 7, 2019; Published: November 27, 2019
Copyright: © 2019 Qi et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: All relevant data are within the manuscript and its Supporting Information files.
Funding: This project was supported by the High-level Medical Reserved Personnel Training Project of Chongqing, Chongqing Health Commission [grant number 2019GDRC014] and the National Key R&D Program of China [grant number 2017YFC0907303]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Abbreviations: HFMD, Hand, foot and mouth disease; EV71, Enterovirus 71; FDA, Food and Drug Administration; PHC, Primary health centers; SD, Standard deviation
Introduction
Hand, foot and mouth disease (HFMD) is an infectious disease caused by a group of enteroviruses [1]. Most HFMD cases are mild and self-limited; however, some cases rapidly develop serious complications such as meningitis and encephalitis, which can be fatal [2]. Infection with enterovirus 71 (EV71) is of particular concern as it is responsible for most of the severe and fatal HFMD cases, particularly in the Asia-Pacific region [3]. In China, EV71 accounted for more than 90% of laboratory-confirmed fatal HFMD cases between 2008 and 2013 [4]. Moreover, EV71 is also associated with many severe diseases in young children (aged < 5 years), including aseptic meningitis and encephalitis [5, 6]. To date, there is no effective antiviral medications to protect against EV71-associated diseases [7, 8]. The preventive measures suggested by World Health Organization are good hygiene, frequent hand washing and social distancing, which seem to have a limited effect on EV71-associated HFMD control and prevention [7, 9]. EV71 vaccine has been viewed as a promising prevention measure against severe and fatal HFMD [10]. Three inactivated EV71 vaccines were licensed by the Chinese Food and Drug Administration (FDA) in December 2015 and recommended for children [11–13]. However, limited data have been collected on the acceptability of EV71 vaccine among parents since the approval of the vaccine by Chinese government.
Chongqing, the largest municipality under direct control of the national government in China, is located in the southwestern China, which is one of the most seriously affected areas by HFMD in China [14]. EV71 vaccine has been put into market in Chongqing since 2016. The aim of this study was to assess parents’ knowledge, attitudes and practices regarding HFMD and EV71 vaccination in Chongqing and to identify potential factors influencing EV71-vaccine uptake.
Materials and methods
From July 17 to August 14 in 2017, we conducted a cross-sectional survey in 18 primary health centers in Chongqing. A total of 1,080 parents were selected via a three-stage sampling method. At stage 1, nine districts/counties were randomly selected from 39 districts/counties of Chongqing. At stage 2, two primary health centers (PHCs) were randomly selected from each of the sampled district/county, resulting in 18 selected PHCs. At the final stage, 60 parents of children under 5 who attended the PHCs to have their children vaccinated with EV71 vaccine or other vaccines, were selected and invited to participate in a face-to-face interview in each PHC during the proposed study period. The first parent was selected randomly and then the subsequent parents were selected contiguously till the completion of the required sample size. We excluded those parents whose children had a history of suffering HFMD.
The questionnaire was developed by the research team based on literature review [15–16] and tested in a pilot study. The questionnaire included three parts: (1) demographic characteristics, such as age, gender, education level, number of children, and monthly family income; (2) awareness and knowledge of HFMD and EV71 vaccine; (3) acceptability and reasons for not accepting EV71 vaccination.
Awareness of HFMD and EV71 were assessed with the questions “Before today, had you heard of HFMD?” and “Before today, had you heard of EV71 vaccine?”. Parents who answered “yes” to the question were considered to be aware of HFMD and EV71 vaccine. Those who were not aware of EV71 vaccine were given basic information on EV71 vaccine by the interviewer prior to continuing the interview.
Knowledge of HFMD was collectively assessed with 12 single choice question with items of “yes”, “no”, and “don’t know”. Each correct answer was given one point, and each incorrect answer or “don’t know” was given zero point. The total knowledge score ranged from 0 to 12. Finally, all respondents were divided into two groups based on their total knowledge score: good (≥ 8 correct out of 12) and poor (< 8 correct out of 12).The questions “have you already vaccinated your children with EV71 vaccine?” and “are you willing to vaccinate your children with EV71 vaccine?” were used to assess the acceptability of EV71 vaccine. Parents who answered yes to either of the two questions were considered to have good willingness to take EV71 vaccine. For parents who answered “no” to both questions were further asked to give their reasons for not accepting vaccine with a multiple choice question with 5 specified reasons and one open choice (“Others, please specify”).
We conducted a pilot survey with a small sample of participants (n = 50) to test the acceptability and feasibility of the questionnaire. Based on the results of the pilot survey, some minor wording changes were made in the revised version, which was then used in this study.
Statistical analysis
Descriptive statistics were obtained for all survey items. The Chi-square tests were used for comparisons between categorical variables. Univariate analysis was conducted to compare factors influencing acceptability of EV71 vaccinations, for those factors with statistical significance (p < 0.05) were included in multivariate logistic regression analysis. SPSS Statistics software (Release 25.0, SPSS Inc, and IBM Company, Chicago, IL, USA) was used for all of the statistical analyses.
Results
Demographics
A total of 1, 080 parents were invited to participate in the survey. Of them, 992 (91.9%) parents completed the questionnaires and were included in the analysis, while 88 parents refused. Demographic characteristics of participants were summarized in Table 1.
Of the 992 participants, 67.8% (673/992) were mothers and 32.2% (319/992) were fathers with the mean age of 28.5 (range: 20–44 years). Most commonly reported education level was high school or above (58.1%, 576/992). Of the 992 children who were vaccinated on the survey days, 50.3% (499/992) were boys and 49.7% (493/992) were girls with mean age of 1.6 (range: 1 month– 5 years old). Majority of them (81.2%, 806/992) were scattered children and 18.8% (186/992) were preschool children.
Awareness and knowledge of HFMD
Most (83.0%, 823/992) of the participants had heard of HFMD before the investigation. However, their knowledge regarding the characteristic symptoms, infectiousness, prevention measures and transmission routes of HFMD varied significantly (Table 2). Indeed, 75.1% of them knew HFMD is infectious and characterized by non-itchy red rash with blisters on the hands and feet and painful mouth ulcers (60.4%), whereas the awareness of other aspects was poor. Particularly, less than one third of participants knew the transmission routes of HFMD.
The mean score of HFMD knowledge was 5.0 (SD = 3.5) out of 12. A total of 369 (37.2%) participants were classified as with good knowledge related to HFMD, 454 (62.8%) were classified as having poor knowledge (Table 3).
Information about EV71 vaccine
Only 386 (38.9%) participants had heard of the EV71 vaccine before, and most got the information about EV71 vaccine from their physicians (Fig 1).
The blue columns indicate the proportions of participants got information from each source.
Regarding their most trusted vaccine information source, the majority of participants preferred physicians (94.4%, 936/992) and vaccination certificate (93.1%, 924/992), followed by friends (57.1%, 566/992) and lectures (50.4%, 500/992), while other information channels were considered as less credible (Fig 2).
The blue columns indicate the participants’ credibility of each vaccine information source.
Acceptability of EV71 vaccine
A total of 279 participants (28.1%) had already vaccinated their children with EV71 vaccine by the survey time and 271 (27.3%) expressed willingness to vaccinate their children after a short-time education about EV71 vaccine during the investigation. However, 442 (44.6%) participants declined vaccination. There were a few of possible reasons for unwillingness to vaccinate their children with EV71 vaccine: 56.6% (250/442) respondents concerned about the safety of the vaccine, and 48.3% (213/442) concerned about its efficacy. In addition, 38.3% (169/442) doubted its necessity. 24.4% (108/442) of the participants thought that the vaccine too expensive, and 11.3% (50/442) considered HFMD as a mild illness (Fig 3).
The blue columns indicate the proportions of possible reasons for declining EV71 vaccination.
The characteristics of participants who accepted EV71 vaccine and those who declined EV71 vaccine were compared by χ2 test and presented in Table 4. In univariate analysis, the following factors were statistical significantly associated with the acceptability: parents’ education level and knowledge of HFMD, monthly family income and children's category. All covariables were included in the multiple logistic regression model.
From the multiple logistic regression analysis, children’s category, parents’ education level and knowledge of HFMD were significantly and independently associated with the acceptability of EV71 vaccine after adjusting for the other variables in the model (Table 5). Parents of scattered children were 1.79 times more likely to vaccinate their children (OR = 1.79, 95CI: 1.29–2.50) compared to those of pre-school children. Parents with education level of high school or above were 1.54 times more likely to vaccinate their children (OR = 1.54, 95CI: 1.08–2.21) than those with education level of primary school or below. Parents with good knowledge of HFMD were 1.67 times more likely to vaccinate their children (OR = 1.67, 95CI: 1.27–2.20) compared to those with poor knowledge of HFMD.
Discussion
EV71 vaccines have been put into market in China since 2016 and have been viewed as a promising prevention measure against severe and fatal HFMD [12, 17]. The objective of this study was to provide useful information for further research on HFMD vaccine and immunization strategy of the EV71 vaccine. The result indicated a suboptimal EV71 vaccine acceptance among parents of under-five in Chongqing, China. Only 28.1% of participants had their children vaccinated and 44.6% declined even after being given the official EV71 vaccine recommendation statement during the investigation. This coverage rate is lower than other extra expanded immunization program (EPI) vaccines classified as class 2, which are not free of charge, such as chickenpox vaccine, which was 44.7% in urban area of Chongqing [18]. Several factors might be proposed to explain the low vaccine acceptability.
Firstly, lack of propaganda about the EV71 vaccine and the fact that the vaccine was available recently. In this study, only 38.9% of participants had heard of EV71 vaccine before the investigation. The result showed 27.3% of participants expressed willing to vaccinate their children after a short-time education about EV71 vaccine during the investigation. This finding suggests health publicity and education on EV71 vaccine should be enhanced. Regarding the different vaccine information sources, physician was the most credible source, followed by vaccination certificate. Therefore, it would be helpful for doctors to recommend EV71 vaccine to parents and provide them with information about the risks of EV71 infection and benefits of vaccination [19]. It is also advisable to conduct studies to explore the factors associated with recommendation of EV71 vaccination by physicians. Moreover, promotion of EV71 vaccine through vaccination certificate might be also a cost-effective immunization implementation strategy.
Secondly, poor knowledge of HFMD among parents also contributed to the poor acceptance of EV71 vaccine. The mean score of HFMD knowledge was only 5.0 out of 12. The multivariable analysis showed that parents’ knowledge on HFMD was significantly positively associated with acceptability, as was reported by other similar studies [20–22]. Furthermore, parents of higher education level and of scatter children were more likely to vaccinate their children, which is consistent with other studies [23, 24]. The findings suggest that enhancing public education on HFMD knowledge might improve their willingness to vaccinate their children, and the information needs to be communicated in simplified language for parents with lower education level. EV71 vaccination among children is one of the most effective means of preventing HFMD transmission in such places as kindergartens and nurseries, where the virus can be rapidly spread. Therefore, it is advisable to enhance health publicity and education on HFMD and EV71 vaccine in these places.
Thirdly, lack of confidence in the safety and efficacy of the EV71 vaccine directly lead to a low acceptance, which is similar to previous studies on other vaccines [25, 26]. The top two reasons against vaccination were “concern about the safety of vaccine” and “concern about the efficacy of vaccine”, accounting for 56.6% and 48.3% of those participants unwilling to vaccinate their children. It reflected the misconception about EV71 vaccine among parents. Nowadays, in China, there is an irrational panic and wide-spread concern about vaccination as result of many misreported adverse events about vaccination [27]. When a new vaccine such as EV71 vaccine is licensed for use, the people become more cautious about it. Therefore, future health education campaigns and messages should be aimed at easing concerns about safety and effectiveness of EV71 vaccine in parents.
There is no single intervention strategy that works for all aspects of vaccination hesitancy. The tailed strategies to improve vaccine acceptability should be developed based on the different areas and vaccines. According to the results in our study, we can improve the acceptability of EV71 vaccine from the following three aspects. Firstly, HFMD knowledge level and awareness of EV71 vaccine of the target parents must be improved. Appropriate incentives should be given to physicians to increase their involvement [28]. The contents of the health education should include those aspects which parents with poor knowledge, such as the routes of transmission. Secondly, people’s concerns about safety and efficacy of EV71 vaccine should be echoed. To help address misconceptions among parents, tailed educational messages should be targeted at parents. Thirdly, strong physician recommendation and promotion through vaccination certificate were key facilitators to optimize uptake of EV71 vaccine in this region.
Our study could be interpreted with some limitations. Firstly, the convenient samples of parents who attended the PHCs to vaccinate their children during the proposed study period may not adequately represent the population in Chongqing. Secondly, the cross-sectional nature of this study limits the extent to which we can evaluate changes in KAP across time. Finally, the EV71 vaccination status of children was self-reported and not verified through records.
Conclusions
In conclusion, parents’ knowledge about HFMD was not sufficient, and nearly half of parents expressed unwillingness to vaccinate their children with EV71 vaccine in Chongqing. Misconceptions about EV71 vaccination were prevalent among parents. Our findings stress that more efforts by health authorities in Chongqing are needed to increase the acceptability of EV71 vaccine, especially for parents of preschool children with lower education level.
Acknowledgments
We would like to thank all participants, discussion facilitators, and consultants in this study.
References
- 1. Goksugur N, Goksugur S. Images in clinical medicine. Hand, foot, and mouth disease. New England Journal of Medicine. 2010;362(14): e49. pmid:20375401
- 2. Wong SS, Yip CC, Lau SK, Yuen KY. Human enterovirus 71 and hand, foot and mouth disease. Epidemiol Infect. 2010;138: 1071–89. pmid:20056019
- 3. Gao LD, Hu SX, Zhang H, luo KW, Liu YZ, Xu QH, et al. Correlation Analysis of EV71 Detection and Case Severity in Hand, Foot, and Mouth Disease in the Hunan Province of China. Plos One. 2014; 9(6): e100003. pmid:24941257
- 4. Xing W, Liao Q, Viboud C, Zhang J, Sun J, Wu JT, et al. Hand, foot, and mouth disease in China, 2008–12: an epidemiological study. The Lancet Infectious Diseases. 2014;14: 308–18. pmid:24485991
- 5. Jane Q. Enterovirus 71 infection: a new threat to global public health? Lancet Neurology. 2008;7(10): 868–9. pmid:18848307
- 6.
Hand-Foot-Mouth Disease: Signs and Symptoms. Available at: http://wwwcdcgov/hand-foot-mouth/about/signs-symptomshtml (accessed on 19 November 2014).
- 7.
Guideline for diagnosis and treatment of hand, foot and mouth disease 2010. Available at: http://wwwnhfpcgovcn/zwgkzt/wsbysj/201004/46884shtml 2010.
- 8. Ooi MH, Wong SH, Lewthwaite P, Cardosa MJ, Solomon T. Clinical features, diagnosis, and management of enterovirus 71. Lancet Neurology. 2010;9(11): 1097–105. pmid:20965438
- 9. Gao LD, Hu SX, Zhang H, Luo KM, Liu YZ, Xu QH, et al. Correlation Analysis of EV71 Detection and Case Severity in Hand, Foot, and Mouth Disease in the Hunan Province of China. Plos One. 2014;9(6): e100003. pmid:24941257
- 10. Wu JT, Jit M, Zheng YM, leung K, Xing WJ, Yang J, et al. Routine Pediatric Enterovirus 71 Vaccination in China: a Cost-Effectiveness Analysis. Plos Medicine. 2016;13(3): e1001975. pmid:26978565
- 11. Zhu FC, Xu WB, Xia JL, liang ZL, liu Y, Zhang XF, et al. Efficacy, safety, and immunogenicity of an enterovirus 71 vaccine in China. N Engl J Med. 2014;370(9): 818–28. pmid:24571754
- 12.
Technical Guideline for Inactive enterovirus 71 vaccine in China. http://wwwchinacdccn/zxdt/201606/t20160608_131032.
- 13. Li RC, Liu LD, Mo ZJ, Wang XY, Xia JL, Liang ZL, et al. An inactivated enterovirus 71 vaccine in healthy children. New England Journal of Medicine. 2014;370(9): 829–37. pmid:24571755
- 14. Qi L, Tang WG, Zhao H, Ling H, Su K, Zhao H, et al. Epidemiological Characteristics and Spatial-Temporal Distribution of Hand, Foot, and Mouth Disease in Chongqing, China, 2009–2016. International Journal of Environmental Research and Public Health. 2018;15: 270. pmid:29401726
- 15. Ma T, Shen T, Lin D, Wang YM, Song XJ, Yin XJ, et al. Cognition on hand-foot-mouth disease and willingness to accept EV71 vaccination of parents of children under 5 years in a district. Modern Preventive Medicine. 2016; 43(23): 4310–13, 18.
- 16. Li HX, Zhang WZ, Chen DN, Wu D, Shi JX, Ma YX. Investigation on the cognition of hand-foot-mouth disease (HFMD) and EV71 vaccination intention of the parents (infants under 5 years old). Journal of Public Health and Preventive Medicine. 2016; 27(05): 25–28.
- 17. Mao QY, Wang YP, Bian LL, Xu M, Liang ZL. EV-A71 vaccine licensure: a first step for multivalent enterovirus vaccine to control HFMD and other severe diseases. Emerging Microbes & Infections. 2016;5(7): e75. pmid:27436364
- 18. Jiang Y, Yin H, Shi YH, Yuan YF, Cao WN, Zeng QQ, et al. Immunization status of extra EPI Vaccines and its influencing factors among children aged 1–6 years in Chongqing. Chinese Journal of Health Education. 2013; 29(07): 605–07, 30. 0.16168/j.cnki.issn.1002-9982.2013.07.024
- 19. Olatunbosun OD, Esterhuizen TM, Wiysonge CS. A cross sectional survey to evaluate knowledge, attitudes and practices regarding seasonal influenza and influenza vaccination among diabetics in Pretoria, South Africa. Vaccine. 2017;35(47): 6375. pmid:29037580
- 20. Rehmani R, Memon. Knowledge, attitudes and beliefs regarding influenza vaccination among healthcare workers in a Saudi hospital. Vaccine. 2010;28(26): 4283–7. pmid:20441803
- 21. Wodi AP, Samy S, Ezeanolue E, Lamour R, Patel R, Budnick LD, et al. Influenza Vaccine: Immunization Rates, Knowledge, and Attitudes of Resident Physicians in an Urban Teaching Hospita. Infect Control Hosp Epidemiol. 2005;26(11): 867–73. pmid:16320982
- 22. Cvjetkovic SJ, Jeremic VL, Tiosavljevic DV. Knowledge and attitudes toward vaccination: A survey of Serbian students. J Infect Public Health. 2017;10(5): 649–56. pmid:28669785
- 23.
WHO:Vaccine hesitancy: A growing challenge for immunization programmes. Available: http://wwwwhoint/en/news-room/detail/18-08-2015-vaccine-hesitancy-a-growing-challenge-for-immunization-programmes.
- 24. Rosenthal SL, Rupp R, Zimet GD, Meza HM, Loza ML, Short MB, et al. Uptake of HPV Vaccine: Demographics, Sexual History and Values, Parenting Style, and Vaccine Attitudes. Journal of Adolescent Health. 2008; 43(3): 239–45. pmid:18710678
- 25. Zhang J WAE, Norman I J. Seasonal influenza vaccination knowledge, risk perception, health beliefs and vaccination behaviours of nurses. Epidemiology & Infection. 2012;40(9): 1569–77. pmid:22093804
- 26. Song Y, Zhang T, Chen L, Yi B, Hao X, Zhou S, et al. Increasing seasonal influenza vaccination among high risk groups in China: Do community healthcare workers have a role to play? Vaccine. 2017;35(33): 4060–3. pmid:28668569
- 27. Chen B, Zhang JM, Jiang Z, Shao J, Jiang T, Wang Z, et al. Media and public reactions toward vaccination during the 'hepatitis B vaccine crisis' in China. Vaccine. 2015;33(15): 1780–5. pmid:25731787
- 28. Smailbegovic MS, Laing GJ, Bedford H. Why do parents decide against immunization? The effect of health beliefs and health professionals. Child Care Health & Development. 2003;29(4): 303–11. pmid:12823336